{"id":"guanidine","rwe":[{"pmid":"41903745","year":"2026","title":"Hydrophilic Cationic Surface Modification Confers Simultaneous Antibacterial and Antithrombotic Properties to Blood-Contacting Devices.","finding":"","journal":"Acta biomaterialia","studyType":"Clinical Study"},{"pmid":"41892949","year":"2026","title":"Discovery of Marine-Inspired Guanidine-Based PDE4 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.","finding":"","journal":"Marine drugs","studyType":"Clinical Study"},{"pmid":"41880913","year":"2026","title":"Trinity synergy of guanidine-functionalized polymer brush-modified β-cyclodextrin polymer magnetic beads for recognition of phosphopeptides in serum of Alzheimer's disease.","finding":"","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences","studyType":"Clinical Study"},{"pmid":"41877984","year":"2026","title":"Synergistic diselenide/guanidine catalyzed dehydrophosphorylation of 2-nitrobenzhydrols to access C-stereogenic phosphinates.","finding":"","journal":"Chemical science","studyType":"Clinical Study"},{"pmid":"41870645","year":"2026","title":"Efficient degradation of a sulfur mustard simulant by a hydrogen peroxide/guanidine system: mechanism and performance.","finding":"","journal":"Environmental geochemistry and health","studyType":"Clinical Study"}],"tags":[{"label":"Acetylcholine Releasing Agent","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Voltage-gated potassium channel","category":"target"},{"label":"KCNA1","category":"gene"},{"label":"KCNA10","category":"gene"},{"label":"KCNA2","category":"gene"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Eaton-Lambert syndrome","category":"indication"},{"label":"Merck Sharp Dohme","category":"company"},{"label":"Approved 1930s","category":"decade"}],"phase":"marketed","safety":{"safetySignals":[{"llr":304.508,"date":"","count":50,"signal":"Pulmonary pain","source":"DrugCentral FAERS","actionTaken":"Reported 50 times (LLR=305)"}],"commonSideEffects":[],"contraindications":["Anemia","Breastfeeding (mother)","Leukopenia","Pregnancy, function","Thrombocytopenic disorder"]},"trials":[],"aliases":[],"company":"Merck & Co.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GUANIDINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:20:36.788949+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:20:42.638049+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUANIDINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:20:42.969424+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL821/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:20:44.057283+00:00"}},"allNames":"guanidin","offLabel":[],"synonyms":["guanidine","aminoformamidine","iminourea","guanidin","carbamamidine","guanidine hydrochloride","guanidine HCl"],"timeline":[{"date":"1939-10-02","type":"positive","source":"DrugCentral","milestone":"FDA approval (Merck Sharp Dohme)"}],"approvals":[{"date":"1939-10-02","orphan":false,"company":"MERCK SHARP DOHME","regulator":"FDA"}],"brandName":"Guanidin","ecosystem":[{"indication":"Eaton-Lambert syndrome","otherDrugs":[{"name":"amifampridine","slug":"amifampridine","company":"Catalyst Pharms"}],"globalPrevalence":null}],"mechanism":{"target":"Voltage-gated potassium channel","novelty":"First-in-class","targets":[{"gene":"KCNA1","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 1"},{"gene":"KCNA10","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 10"},{"gene":"KCNA2","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 2"},{"gene":"KCNA3","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 3"},{"gene":"KCNA4","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 4"},{"gene":"KCNA5","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 5"},{"gene":"KCNA6","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 6"},{"gene":"KCNA7","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily A member 7"},{"gene":"KCNB1","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily B member 1"},{"gene":"KCNB2","source":"DrugCentral","target":"Voltage-gated potassium channel","protein":"Potassium voltage-gated channel subfamily B member 2"}],"modality":"Small Molecule","drugClass":"Acetylcholine Releasing Agent","explanation":"","oneSentence":"","technicalDetail":"Guanidin acts as an acetylcholine releasing agent by modulating voltage-gated potassium channels, which leads to an increase in acetylcholine release and subsequent improvement in muscle strength and function."},"commercial":{"launchDate":"1939","_launchSource":"DrugCentral (FDA 1939-10-02, MERCK SHARP DOHME)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1344","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=GUANIDINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUANIDINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T11:50:17.365624","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:45.744589+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"amifampridine","drugSlug":"amifampridine","fdaApproval":"2018-11-28","patentExpiry":"May 26, 2034","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"fampridine","drugSlug":"fampridine","fdaApproval":"2010-01-22","relationship":"same-target"}],"genericName":"guanidine","indications":{"approved":[{"name":"Eaton-Lambert syndrome","source":"DrugCentral","snomedId":56989000,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"amifampridine","brandName":"amifampridine","genericName":"amifampridine","approvalYear":"2018","relationship":"same-target"},{"drugId":"fampridine","brandName":"fampridine","genericName":"fampridine","approvalYear":"2010","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07223671","phase":"PHASE1","title":"Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":["Healthy Volunteers"],"enrollment":30,"completionDate":"2026-03-19"},{"nctId":"NCT02581137","phase":"PHASE2","title":"Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-06-10","conditions":["Erythroplakia","Hyperplasia","Oral Cavity Carcinoma","Oral Leukoplakia"],"enrollment":26,"completionDate":"2026-12-19"},{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":["Advanced Solid Malignancies"],"enrollment":41,"completionDate":"2026-04-30"},{"nctId":"NCT02122185","phase":"PHASE2","title":"Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02-25","conditions":["Brenner Tumor","Malignant Ascites","Malignant Pleural Effusion","Ovarian Clear Cell Cystadenocarcinoma","Ovarian Endometrioid Adenocarcinoma","Ovarian Mixed Epithelial Carcinoma","Ovarian Serous Cystadenocarcinoma","Ovarian Undifferentiated Adenocarcinoma","Recurrent Fallopian Tube Cancer","Recurrent Ovarian Epithelial Cancer","Recurrent Ovarian Germ Cell Tumor","Recurrent Primary Peritoneal Cavity Cancer","Stage IIIA Fallopian Tube Cancer","Stage IIIA Ovarian Epithelial Cancer","Stage IIIA Ovarian Germ Cell Tumor","Stage IIIA Primary Peritoneal Cavity Cancer","Stage IIIB Fallopian Tube Cancer","Stage IIIB Ovarian Epithelial Cancer","Stage IIIB Ovarian Germ Cell Tumor","Stage IIIB Primary Peritoneal Cavity Cancer","Stage IIIC Fallopian Tube Cancer","Stage IIIC Ovarian Epithelial Cancer","Stage IIIC Ovarian Germ Cell Tumor","Stage IIIC Primary Peritoneal Cavity Cancer","Stage IV Fallopian Tube Cancer","Stage IV Ovarian Epithelial Cancer","Stage IV Ovarian Germ Cell Tumor","Stage IV Primary Peritoneal Cavity Cancer"],"enrollment":111,"completionDate":"2024-10-08"},{"nctId":"NCT04530383","phase":"PHASE2","title":"Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function","status":"NOT_YET_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2026-04-15","conditions":["Cystic Fibrosis-related Diabetes","Cystic Fibrosis"],"enrollment":30,"completionDate":"2028-07-15"},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":["Tuberculosis","Pulmonary Tuberculosis","HIV Coinfection"],"enrollment":112,"completionDate":"2025-08-15"},{"nctId":"NCT07485764","phase":"PHASE4","title":"Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-06","conditions":["Psoriasis","Plaque Psoriasis","Moderate-to-severe Plaque Psoriasis","Overweight , Obesity"],"enrollment":186,"completionDate":"2029-06"},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":["Periodontal Disease (PD)","Cardio Vascular Disease","Oral-Systemic Link","Vascular Dysfunction","Endothelial Function and Arterial Stiffness"],"enrollment":30,"completionDate":"2028-07-01"},{"nctId":"NCT07489924","phase":"PHASE4","title":"Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Colima","startDate":"2023-01-08","conditions":["Periodontal Diseases","Diabetes Mellitus Type 2"],"enrollment":20,"completionDate":"2026-07-31"},{"nctId":"NCT00445627","phase":"","title":"Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-06-18","conditions":["Obesity","Overweight","Diabetes Mellitus, Type 2"],"enrollment":82,"completionDate":""},{"nctId":"NCT06483321","phase":"NA","title":"Effect of Creatine Supplementation on Physical Performance in Vegan Subjects","status":"COMPLETED","sponsor":"Universidad Francisco de Vitoria","startDate":"2024-07-30","conditions":["Deficiency; Diet"],"enrollment":20,"completionDate":"2024-09-30"},{"nctId":"NCT07368569","phase":"PHASE1","title":"A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2026-02-06","conditions":["Healthy"],"enrollment":14,"completionDate":"2026-03-17"},{"nctId":"NCT07460336","phase":"NA","title":"Effects of Cofrogliptin on Beta-Cell Function in LADA Patients","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-03-15","conditions":["Latent Autoimmune Diabetes in Adults (LADA)"],"enrollment":84,"completionDate":"2027-12-31"},{"nctId":"NCT05663515","phase":"","title":"A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":["Pancreatic Cancer"],"enrollment":24000,"completionDate":"2026-10-01"},{"nctId":"NCT02365597","phase":"PHASE2","title":"An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2015-04-22","conditions":["Urothelial Cancer"],"enrollment":239,"completionDate":"2027-03-31"},{"nctId":"NCT03499704","phase":"PHASE4","title":"A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy","status":"COMPLETED","sponsor":"Celltrion Pharm, Inc.","startDate":"2020-02-11","conditions":["Diabetes Mellitus, Type 2"],"enrollment":133,"completionDate":"2024-01-16"},{"nctId":"NCT05013112","phase":"NA","title":"Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2023-01-01","conditions":["Kidney Transplantation","Metabolic Disorder","Metformin","Empagliflozin"],"enrollment":105,"completionDate":"2025-12-31"},{"nctId":"NCT07045142","phase":"PHASE3","title":"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-07-01","conditions":["Schizophrenia"],"enrollment":400,"completionDate":"2028-06-01"},{"nctId":"NCT07472179","phase":"NA","title":"Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS","status":"COMPLETED","sponsor":"Mst.Sumyara Khatun","startDate":"2024-08-12","conditions":["PCOS(Insulin Resistant)"],"enrollment":60,"completionDate":"2026-02-20"},{"nctId":"NCT02437656","phase":"PHASE2","title":"Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2015-05","conditions":["Rectal Cancer"],"enrollment":60,"completionDate":"2017-03"},{"nctId":"NCT07475676","phase":"NA","title":"Effects of Short-term Acute Creatine Supplementation on Power, Speed and Muscular Strengths in Young Football Players","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-03-01","conditions":["Performance Enhancement"],"enrollment":20,"completionDate":"2026-04-13"},{"nctId":"NCT07472426","phase":"NA","title":"Effects of Creatine Supplementation on Cognitive Measures and Markers of Acute Kidney Injury After Exercise in the Heat","status":"RECRUITING","sponsor":"University of Northern Iowa","startDate":"2026-03-12","conditions":["Acute Kidney Injury","Exertional Heat Illness"],"enrollment":20,"completionDate":"2027-05"},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":["Healthspan Improvement","Aging","Longevity"],"enrollment":30,"completionDate":"2026-04"},{"nctId":"NCT03424005","phase":"PHASE1,PHASE2","title":"A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2018-03-30","conditions":["Metastatic Breast Cancer"],"enrollment":792,"completionDate":"2030-09-30"},{"nctId":"NCT07226453","phase":"PHASE2","title":"Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-04","conditions":["Posterior Fossa Ependymal Tumor"],"enrollment":30,"completionDate":"2030-03-31"},{"nctId":"NCT00107289","phase":"PHASE2","title":"Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-05","conditions":["Neuroblastoma","Pheochromocytoma"],"enrollment":200,"completionDate":"2027-05"},{"nctId":"NCT07463092","phase":"NA","title":"Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-03","conditions":["Prostate Cancer","Sarcopenia"],"enrollment":34,"completionDate":"2029-01"},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":["Osteo Arthritis Knee"],"enrollment":70,"completionDate":"2027-11-20"},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":["Parkinson Disease"],"enrollment":60,"completionDate":"2025-01-20"},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":["Carcinoma, Non-Small-Cell Lung"],"enrollment":300,"completionDate":"2032-01-31"},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":["Obesity","Metabolic Syndrome X"],"enrollment":128,"completionDate":"2014-01-09"},{"nctId":"NCT07225335","phase":"NA","title":"Impact of OptiCreatine on Plasma Creatine and Gastrointestinal Effects in Males and Females","status":"COMPLETED","sponsor":"TSI Group LTD","startDate":"2025-11-05","conditions":["Creatine Absorption in Healthy Adults"],"enrollment":17,"completionDate":"2025-12-19"},{"nctId":"NCT07372625","phase":"PHASE1","title":"A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.","status":"RECRUITING","sponsor":"PMV Pharmaceuticals, Inc","startDate":"2026-02-04","conditions":["TP53 Y220C Mutation","Advanced Solid Tumors"],"enrollment":14,"completionDate":"2028-01"},{"nctId":"NCT07027800","phase":"NA","title":"High Intensity Resistance Training + Creatine in Perimenopause","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-06-02","conditions":["Perimenopause"],"enrollment":55,"completionDate":"2025-12-15"},{"nctId":"NCT03006172","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2016-12-13","conditions":["Breast Cancer","Solid Tumor"],"enrollment":200,"completionDate":"2026-12-31"},{"nctId":"NCT07459595","phase":"PHASE1","title":"Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Fatima Tariq","startDate":"2026-05-01","conditions":["Polycystic Ovarian Syndrome (PCOS)"],"enrollment":60,"completionDate":"2026-07-31"},{"nctId":"NCT05164081","phase":"PHASE3","title":"Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture","status":"ACTIVE_NOT_RECRUITING","sponsor":"Umeå University","startDate":"2022-01-01","conditions":["Femoral Neck Fractures","Prosthetic Infection"],"enrollment":7000,"completionDate":"2027-01-31"},{"nctId":"NCT07462078","phase":"PHASE4","title":"The Effect of Lifestyle Modification on the Risk of Prediabetes Among Patients Attending Outpatient Clinic.","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-09-25","conditions":["PreDiabetes"],"enrollment":124,"completionDate":"2025-06-02"},{"nctId":"NCT06975111","phase":"PHASE2,PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":["Menopause","Menopause Hot Flashes","Menopause Related Conditions","Cardiovascular"],"enrollment":200,"completionDate":"2030-10-01"},{"nctId":"NCT07066722","phase":"PHASE1","title":"A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2025-07-07","conditions":["HIV Infections"],"enrollment":126,"completionDate":"2025-12-17"},{"nctId":"NCT07029243","phase":"NA","title":"Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-04","conditions":["Cirrhosis","Frailty","Sarcopenia"],"enrollment":100,"completionDate":"2026-12"},{"nctId":"NCT05965908","phase":"PHASE3","title":"Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-01-30","conditions":["Polycystic Ovary"],"enrollment":150,"completionDate":"2025-03-30"},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":["Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy","Severe Proteinuria Due to Idiopathic Membranous Nephropathy"],"enrollment":23,"completionDate":"2026-06-30"},{"nctId":"NCT07452913","phase":"PHASE4","title":"Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Bahria University","startDate":"2026-01-01","conditions":["Type 2 Diabetes Mellitus"],"enrollment":110,"completionDate":"2026-06-30"},{"nctId":"NCT02946996","phase":"PHASE2","title":"Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy","status":"TERMINATED","sponsor":"Medical University of South Carolina","startDate":"2016-12-28","conditions":["Prostate Cancer"],"enrollment":41,"completionDate":"2024-08-19"},{"nctId":"NCT07451496","phase":"NA","title":"PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2025-09-29","conditions":["Ageing"],"enrollment":20,"completionDate":"2026-06-30"},{"nctId":"NCT06627270","phase":"PHASE2","title":"Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-03-11","conditions":["Oral Squamous Cell Carcinoma","Oral Cancer","Head and Neck Cancer","Head and Neck Carcinoma"],"enrollment":30,"completionDate":"2027-10-01"},{"nctId":"NCT07291297","phase":"PHASE2","title":"Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03-04","conditions":["Sarcoma Metastatic","Sarcoma, Soft Tissue"],"enrollment":50,"completionDate":"2033-10"},{"nctId":"NCT06408246","phase":"PHASE2","title":"ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression","status":"RECRUITING","sponsor":"Stanford University","startDate":"2026-03-03","conditions":["Depression"],"enrollment":162,"completionDate":"2029-02-01"},{"nctId":"NCT07453069","phase":"PHASE2","title":"Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle","status":"NOT_YET_RECRUITING","sponsor":"Freya Biosciences ApS","startDate":"2026-04-15","conditions":["Vaginal Dysbiosis"],"enrollment":30,"completionDate":"2027-09-30"},{"nctId":"NCT05856916","phase":"NA","title":"Creatine Supplementation for Improved Voice Performance in the Elderly","status":"SUSPENDED","sponsor":"NYU Langone Health","startDate":"2026-05-01","conditions":["Presbyphonia"],"enrollment":20,"completionDate":"2026-09"},{"nctId":"NCT03982381","phase":"PHASE4","title":"SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2019-09-05","conditions":["Type 2 Diabetes"],"enrollment":2067,"completionDate":"2026-01-31"},{"nctId":"NCT07446400","phase":"PHASE1","title":"A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together","status":"NOT_YET_RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-03-20","conditions":["Healthy Volunteers"],"enrollment":48,"completionDate":"2026-06-12"},{"nctId":"NCT07442006","phase":"PHASE4","title":"Glycemic Variability of Combination Therapies in T2DM","status":"RECRUITING","sponsor":"JW Pharmaceutical","startDate":"2025-10-29","conditions":["Type 2 Diabetes Mellitus (T2DM)"],"enrollment":178,"completionDate":"2027-03-31"},{"nctId":"NCT03710343","phase":"PHASE2","title":"Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2023-11-14","conditions":["Cerebral Palsy"],"enrollment":3,"completionDate":"2025-04-24"},{"nctId":"NCT07436182","phase":"PHASE4","title":"Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-03-01","conditions":["Mitochondria","Metformin"],"enrollment":176,"completionDate":"2026-06-01"},{"nctId":"NCT03764098","phase":"PHASE2","title":"Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-08-10","conditions":["Alcohol Use"],"enrollment":160,"completionDate":"2026-08-31"},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":["Diabetes Mellitus"],"enrollment":255,"completionDate":"2026-03"},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":["Ganglioneuroblastoma","Ganglioneuroblastoma, Nodular","Neuroblastoma"],"enrollment":750,"completionDate":"2030-09-30"},{"nctId":"NCT02572791","phase":"PHASE4","title":"Staph Household Intervention for Eradication (SHINE)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-10","conditions":["Skin and Subcutaneous Tissue Bacterial Infections","Staphylococcus Aureus","MRSA - Methicillin Resistant Staphylococcus Aureus Infection"],"enrollment":835,"completionDate":"2024-12"},{"nctId":"NCT03905941","phase":"EARLY_PHASE1","title":"Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-08-23","conditions":["Polycystic Ovary Syndrome"],"enrollment":0,"completionDate":"2024-11-25"},{"nctId":"NCT06851962","phase":"PHASE4","title":"Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2025-05-26","conditions":["Diabetes Mellitus Type 2"],"enrollment":504,"completionDate":"2026-06-30"},{"nctId":"NCT06611501","phase":"PHASE2","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-05-22","conditions":["Pelvic Pain","Endometriosis"],"enrollment":14,"completionDate":"2027-01"},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":["Heart Failure","Diabetes"],"enrollment":1100,"completionDate":"2025-12-31"},{"nctId":"NCT05900284","phase":"PHASE2","title":"Safety and Feasibility of Metformin for Sepsis Induced AKI","status":"ENROLLING_BY_INVITATION","sponsor":"Hernando Gomez","startDate":"2023-11-08","conditions":["Sepsis","Septic Shock","Acute Kidney Injury","Metformin"],"enrollment":80,"completionDate":"2026-04-30"},{"nctId":"NCT04742673","phase":"PHASE2","title":"Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-05-04","conditions":["Critical Illness","Delirium","Cognitive Impairment"],"enrollment":46,"completionDate":"2025-11-30"},{"nctId":"NCT05648448","phase":"PHASE2","title":"A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2023-02-22","conditions":["Influenza","Influenza, Human"],"enrollment":3000,"completionDate":"2027-01-01"},{"nctId":"NCT05041907","phase":"PHASE2","title":"Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2021-09-30","conditions":["COVID-19"],"enrollment":3800,"completionDate":"2027-01"},{"nctId":"NCT06429007","phase":"PHASE1","title":"A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury","status":"ENROLLING_BY_INVITATION","sponsor":"Boston Children's Hospital","startDate":"2025-10-01","conditions":["Hypoxic-Ischemic Encephalopathy","HIE","Neurodevelopment","Infant Development"],"enrollment":30,"completionDate":"2029-03-01"},{"nctId":"NCT06495567","phase":"NA","title":"Proof of Concept Creatine Supplementation for Homocystinuria Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2024-08-19","conditions":["Homocystinuria"],"enrollment":9,"completionDate":"2026-12-01"},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":["Lactating Women on Select DOI","Breastfed Infants of Mothers on Select DOI"],"enrollment":1600,"completionDate":"2027-07-31"},{"nctId":"NCT07343999","phase":"NA","title":"EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Burgos","startDate":"2026-06","conditions":["Transthyretin Cardiac Amyloidosis"],"enrollment":102,"completionDate":"2027-09"},{"nctId":"NCT07158411","phase":"PHASE1","title":"Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)","status":"COMPLETED","sponsor":"Deciphera Pharmaceuticals, LLC","startDate":"2025-11-20","conditions":["Healthy Participants"],"enrollment":22,"completionDate":"2026-01-30"},{"nctId":"NCT07222098","phase":"PHASE1","title":"A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-19","conditions":["Healthy"],"enrollment":16,"completionDate":"2025-12-23"},{"nctId":"NCT07399470","phase":"PHASE1","title":"A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.","status":"ACTIVE_NOT_RECRUITING","sponsor":"LG Chem","startDate":"2026-01-09","conditions":["Healthy Volunteers","Fasting Conditions"],"enrollment":58,"completionDate":"2026-02-28"},{"nctId":"NCT06042257","phase":"PHASE2","title":"Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)","status":"TERMINATED","sponsor":"Rachel G. Greenberg, MD, MB, MHS","startDate":"2024-12-09","conditions":["Hyperactivity in Children With Down Syndrome","Impulsivity in Children With Down Syndrome"],"enrollment":3,"completionDate":"2025-08-12"},{"nctId":"NCT07391748","phase":"EARLY_PHASE1","title":"Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers","status":"NOT_YET_RECRUITING","sponsor":"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","startDate":"2026-01-30","conditions":["Pressure Ulcers","Pressure Ulcers Stage III","Pressure Ulcer Prevention","Pressure Ulcer ( Stage 2-3)","Biofilm Formation","Biofilm","Biofilm Removal"],"enrollment":140,"completionDate":"2026-09-30"},{"nctId":"NCT07399535","phase":"PHASE1","title":"Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome","status":"RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2025-02-22","conditions":["Polycystic Ovarian Syndrome (PCOS)","Herbal Medicine","Infertility","Metabolic Disorder"],"enrollment":116,"completionDate":"2026-03-01"},{"nctId":"NCT05767515","phase":"NA","title":"The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2023-07-15","conditions":["Infertility, Female","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries"],"enrollment":120,"completionDate":"2024-03-10"},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":["Monoclonal Gammopathy of Undetermined Significance","Smoldering Multiple Myeloma"],"enrollment":60,"completionDate":"2027-07-31"},{"nctId":"NCT07396844","phase":"PHASE1","title":"The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"LG Chem","startDate":"2026-07-01","conditions":["Healthy","Fasting","Fed"],"enrollment":28,"completionDate":"2026-07-31"},{"nctId":"NCT07387900","phase":"PHASE2","title":"Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02","conditions":["Oral Leukoplakia"],"enrollment":34,"completionDate":"2027-10"},{"nctId":"NCT07173712","phase":"PHASE4","title":"Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Yanbing Li","startDate":"2026-03-15","conditions":["Type 2 Diabetes"],"enrollment":324,"completionDate":"2027-12-31"},{"nctId":"NCT02336087","phase":"PHASE1","title":"Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2016-01-14","conditions":["Pancreatic Adenocarcinoma","Unresectable Pancreatic Carcinoma","Stage III Pancreatic Cancer AJCC v6 and v7","Stage IV Pancreatic Cancer AJCC v6 and v7"],"enrollment":21,"completionDate":"2026-12-09"},{"nctId":"NCT07387679","phase":"NA","title":"Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2024-11-29","conditions":["Polycystic Ovarian Syndrome"],"enrollment":60,"completionDate":"2025-05-28"},{"nctId":"NCT06090227","phase":"PHASE1,PHASE2","title":"AMPK-activation by Metformin in FSGS: AMP-FSGS","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-14","conditions":["Focal Segmental Glomerulosclerosis"],"enrollment":30,"completionDate":"2027-11"},{"nctId":"NCT07363707","phase":"PHASE4","title":"A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2023-05-01","conditions":["NAFLD (Nonalcoholic Fatty Liver Disease)"],"enrollment":108,"completionDate":"2024-03-01"},{"nctId":"NCT06871904","phase":"PHASE1,PHASE2","title":"Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2025-04-07","conditions":["Oral Submucous Fibrosis"],"enrollment":45,"completionDate":"2025-12-30"},{"nctId":"NCT07380841","phase":"NA","title":"Metformin vs Inositol vs Diet vs Combination Therapy in PCOS","status":"COMPLETED","sponsor":"Islamabad Medical and Dental College","startDate":"2025-05-21","conditions":["Polycystic Ovary Syndrome","Insulin Resistance","Metabolic Syndrome"],"enrollment":192,"completionDate":"2026-01-13"},{"nctId":"NCT03076281","phase":"PHASE2","title":"Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2017-04-03","conditions":["Larynx","LIP","Oral Cavity","Pharynx"],"enrollment":7,"completionDate":"2018-12-03"},{"nctId":"NCT07375654","phase":"PHASE1","title":"Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-19","conditions":["Psoriasis"],"enrollment":32,"completionDate":"2025-11-04"},{"nctId":"NCT07372144","phase":"PHASE3","title":"Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment","status":"NOT_YET_RECRUITING","sponsor":"D'Or Institute for Research and Education","startDate":"2026-08-01","conditions":["Breast Cancer"],"enrollment":227,"completionDate":"2028-06-01"},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":["Heart Failure","Diabete Type 2","Arterial Hypertension"],"enrollment":120,"completionDate":"2026-11-01"},{"nctId":"NCT06644131","phase":"NA","title":"Creatine Monohydrate for Mild Traumatic Brain Injury: a Randomised Controlled Pilot Study","status":"COMPLETED","sponsor":"University of Southern Denmark","startDate":"2023-08-01","conditions":["Mild Traumatic Brain Injury","Concussion (Diagnosis)"],"enrollment":34,"completionDate":"2024-12-31"},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":["PreDiabetes","Impaired Glucose Tolerance","Hyperglycemia","Resistance, Insulin"],"enrollment":30,"completionDate":"2026-12"},{"nctId":"NCT07120971","phase":"EARLY_PHASE1","title":"Metformin for Premature Infants With Bronchopulmonary Dysplasia","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-12-19","conditions":["Bronchopulmonary Dysplasia (BPD)"],"enrollment":40,"completionDate":"2030-09-01"},{"nctId":"NCT01175356","phase":"PHASE1","title":"Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-12-21","conditions":["Ganglioneuroblastoma","Localized Resectable Neuroblastoma","Localized Unresectable Neuroblastoma","Regional Neuroblastoma","Stage 4 Neuroblastoma","Stage 4S Neuroblastoma"],"enrollment":99,"completionDate":"2025-12-31"},{"nctId":"NCT07362030","phase":"PHASE1","title":"Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Raynovent Biotech Co., Ltd","startDate":"2025-04-14","conditions":["Obesity"],"enrollment":32,"completionDate":"2026-03-30"},{"nctId":"NCT07357337","phase":"PHASE4","title":"Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris","status":"COMPLETED","sponsor":"Ghurki Trust and Teaching Hospital","startDate":"2025-02-15","conditions":["Acne Vulgaris on the Face","Acne Vulgaris"],"enrollment":68,"completionDate":"2025-10-01"},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":["Medulloblastoma, Childhood","Cognitive Impairment"],"enrollment":140,"completionDate":"2027-11-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000147863","MMSL":"4810","NDDF":"001698","UNII":"JU58VJ6Y3B","VUID":"4019772","CHEBI":"CHEBI:42820","VANDF":"4018993","RXNORM":"50675","UMLSCUI":"C0120446","chemblId":"CHEMBL821","ChEMBL_ID":"CHEMBL821","DRUGBANK_ID":"DB00536","PDB_CHEM_ID":" GAI","PUBCHEM_CID":"3520","SNOMEDCT_US":"109108004","IUPHAR_LIGAND_ID":"4783","SECONDARY_CAS_RN":"50-01-1","MESH_DESCRIPTOR_UI":"D019791"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1939-","companyName":"Merck & Co.","relationship":"Original Developer"}],"publicationCount":12060,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"originalDeveloper":"Merck Sharp Dohme","recentPublications":[{"date":"2026 Mar 27","pmid":"41903745","title":"Hydrophilic Cationic Surface Modification Confers Simultaneous Antibacterial and Antithrombotic Properties to Blood-Contacting Devices.","journal":"Acta biomaterialia"},{"date":"2026 Feb 25","pmid":"41892949","title":"Discovery of Marine-Inspired Guanidine-Based PDE4 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.","journal":"Marine drugs"},{"date":"2026 Mar 20","pmid":"41880913","title":"Trinity synergy of guanidine-functionalized polymer brush-modified β-cyclodextrin polymer magnetic beads for recognition of phosphopeptides in serum of Alzheimer's disease.","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences"},{"date":"2026 Mar 18","pmid":"41877984","title":"Synergistic diselenide/guanidine catalyzed dehydrophosphorylation of 2-nitrobenzhydrols to access C-stereogenic phosphinates.","journal":"Chemical science"},{"date":"2026 Mar 23","pmid":"41870645","title":"Efficient degradation of a sulfur mustard simulant by a hydrogen peroxide/guanidine system: mechanism and performance.","journal":"Environmental geochemistry and health"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Merck & Co.","companyId":"merck","modality":"Small molecule","firstApprovalDate":"1939","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1939-10-02T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:45.744589+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}